Biofilm- and Spore-Disruptive Microgel Data for Clostridioides difficile Infection Therapy

Experimental data from a study on star-shaped poly(l-lysine) dendrimer (G3-PLL9) formulated into hyaluronic acid microgels for targeted oral therapy of Clostridioides difficile infection (CDI). The dataset, shared by I-Fan Lin on figshare, includes results on antimicrobial activity, spore inhibition, biofilm disruption, and treatment outcomes in a murine model. It was last updated on April 22, 2026.

Use Cases

• Analyzing the antimicrobial efficacy of G3-PLL9 dendrimers based on the described bactericidal effects and spore inhibition.
• Modeling site-specific drug release profiles based on the hyaluronidase-mediated degradation mechanism in the inflamed colon.
• Comparing treatment impacts on gut microbiota based on the described preservation of commensal bacteria versus vancomycin.
• Evaluating biofilm disruption potential based on the described activity at subinhibitory concentrations.

Strengths

• Dataset size is 17.4 MB, indicating a substantial amount of experimental data.
• Includes specific, described results from a murine CDI model, such as symptom alleviation and reduced tissue damage.
• Compares key metrics like spore inhibition and microbiota preservation against the standard treatment vancomycin.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect experimental bias inherent to the specific murine model and laboratory conditions described.

Provenance

Source

I-Fan Lin via figshare.

Collection Method

Likely contains experimental results from laboratory assays and animal model studies.

Freshness

Last updated 2026-04-22 08:44:00; freshness should be verified.